Barinthus Biotherapeutics plc. 8-K SEC Filings

Filed On	Filing
09 Sep 2026	8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +3 more The information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference.
01 Sep 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events
25 Aug 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure +1 more
06 Aug 2026	8-K: Results of Operations and Financial Condition
02 Jul 2026	8-K: Submission of Matters to a Vote of Security Holders; Other Events
21 May 2026	8-K: Submission of Matters to a Vote of Security Holders
30 Apr 2026	8-K: Results of Operations and Financial Condition
22 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
31 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
13 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
23 Feb 2026	8-K: Entry into a Material Definitive Agreement
06 Jan 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
10 Dec 2025	8-K: Regulation FD Disclosure
07 Nov 2025	8-K: Results of Operations and Financial Condition
30 Sep 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
07 Aug 2025	8-K: Results of Operations and Financial Condition
10 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
07 May 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +2 more
20 Mar 2025	8-K: Results of Operations and Financial Condition
10 Jan 2025	8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities +2 more

Comments